JESSICA BEMBRY: Open Payments
NPI 1043769490 · BRISTOL, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,946 in 42 payments from 8 companies in 2025. Trend: 2023 $653 · 2024 $821 · 2025 $3,946
Speaker / faculty: $2,730Food & beverage: $1,066Travel & lodging: $150
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 18 | $3,400 |
| AstraZeneca Pharmaceuticals LP | 8 | $183 |
| Eisai Inc. | 6 | $137 |
| Caris MPI, Inc. | 4 | $85 |
| Tactile Systems Technology Inc | 1 | $57 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| Kite Pharma, Inc. | 1 | $23 |
Products named: KEYTRUDA, LYNPARZA, Lenvima, MI CANCER SEEK, Flexitouch Plus, JEMPERLI, LUTATHERA, KEYTRUDA QLEX.
Industry payments across VA — which companies pay providers there.
